Correction

Due to an American Health Consultants error, the dosage information in the Pharmacology Update on Rosiglitazone (Intern Med Alert 1999;21:110) is incorrect. The sentences should have read: "The recommended starting dose for rosiglitazone is 4 mg daily adminstered qd or bid. . . . The difference in glycosylated hemoglobin was significantly greater with 8 mg qd vs. 4 mg bid but not statistically different at 4 mg qd vs. 2 mg bid." We regret any confusion this may have caused.